REFERENCE
Decision Resources.Although Generic Erosion Looms for Risperdal, the Drug Remains First-Line Antipsychotic in the Treatment of Schizophrenia. Media Release: 10 Jul 2008. Available from: URL: http://www.decisionresources.com
Rights and permissions
About this article
Cite this article
Risperdal reigns supreme in schizophrenia. Pharmacoecon. Outcomes News 558, 4 (2008). https://doi.org/10.2165/00151234-200805580-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805580-00011